Ryu, K.J.; Lee, J.Y.; Choi, M.E.; Yoon, S.E.; Cho, J.; Ko, Y.H.; Shim, J.H.; Kim, W.S.; Park, C.; Kim, S.J.
Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma. Cancers 2020, 12, 3548.
https://doi.org/10.3390/cancers12123548
AMA Style
Ryu KJ, Lee JY, Choi ME, Yoon SE, Cho J, Ko YH, Shim JH, Kim WS, Park C, Kim SJ.
Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma. Cancers. 2020; 12(12):3548.
https://doi.org/10.3390/cancers12123548
Chicago/Turabian Style
Ryu, Kyung Ju, Ji Young Lee, Myung Eun Choi, Sang Eun Yoon, Junhun Cho, Young Hyeh Ko, Joon Ho Shim, Won Seog Kim, Chaehwa Park, and Seok Jin Kim.
2020. "Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma" Cancers 12, no. 12: 3548.
https://doi.org/10.3390/cancers12123548
APA Style
Ryu, K. J., Lee, J. Y., Choi, M. E., Yoon, S. E., Cho, J., Ko, Y. H., Shim, J. H., Kim, W. S., Park, C., & Kim, S. J.
(2020). Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma. Cancers, 12(12), 3548.
https://doi.org/10.3390/cancers12123548